• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 中的核苷修饰限制了 2′-5′寡聚腺苷酸合成酶的激活,并增加了对 RNase L 切割的抗性。

Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L.

机构信息

Department of Medicine, 3610 Hamilton Walk, 522B Johnson Pavilion, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Nucleic Acids Res. 2011 Nov;39(21):9329-38. doi: 10.1093/nar/gkr586. Epub 2011 Aug 3.

DOI:10.1093/nar/gkr586
PMID:21813458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3241635/
Abstract

The interferon-induced enzymes 2'-5'-oligoadenylate synthetase (OAS) and RNase L are key components of innate immunity involved in sensory and effector functions following viral infections. Upon binding target RNA, OAS is activated to produce 2'-5'-linked oligoadenylates (2-5A) that activate RNase L, which then cleaves single-stranded self and non-self RNA. Modified nucleosides that are present in cellular transcripts have been shown to suppress activation of several RNA sensors. Here, we demonstrate that in vitro transcribed, unmodified RNA activates OAS, induces RNase L-mediated ribosomal RNA (rRNA) cleavage and is rapidly cleaved by RNase L. In contrast, RNA containing modified nucleosides activates OAS less efficiently and induces limited rRNA cleavage. Nucleoside modifications also make RNA resistant to cleavage by RNase L. Examining translation in RNase L(-/-) cells and mice confirmed that RNase L activity reduces translation of unmodified mRNA, which is not observed with modified mRNA. Additionally, mRNA containing the nucleoside modification pseudouridine is translated longer and has an extended half-life. The observation that modified nucleosides in RNA reduce 2-5A pathway activation joins OAS and RNase L to the list of RNA sensors and effectors whose functions are limited when RNA is modified, confirming the role of nucleoside modifications in suppressing immune recognition of RNA.

摘要

干扰素诱导的酶 2'-5'-寡聚腺苷酸合成酶 (OAS) 和核糖核酸酶 L 是先天免疫的关键组成部分,参与病毒感染后的感应和效应功能。在结合靶 RNA 后,OAS 被激活产生 2'-5'-连接的寡腺苷酸 (2-5A),激活核糖核酸酶 L,然后切割单链自身和非自身 RNA。已经表明,细胞转录物中存在的修饰核苷可抑制几种 RNA 传感器的激活。在这里,我们证明体外转录的、未修饰的 RNA 可激活 OAS,诱导核糖核酸酶 L 介导的核糖体 RNA (rRNA) 切割,并被核糖核酸酶 L 快速切割。相比之下,含有修饰核苷的 RNA 激活 OAS 的效率较低,并诱导有限的 rRNA 切割。核苷修饰还使 RNA 抵抗核糖核酸酶 L 的切割。在核糖核酸酶 L(-/-)细胞和小鼠中进行的翻译研究证实,核糖核酸酶 L 活性降低了未修饰 mRNA 的翻译,而修饰 mRNA 则不会观察到这种情况。此外,含有核苷修饰假尿嘧啶的 mRNA 翻译时间更长,半衰期更长。RNA 中修饰核苷降低 2-5A 途径激活的观察结果将 OAS 和核糖核酸酶 L 加入到 RNA 传感器和效应子的列表中,这些传感器和效应子的功能在 RNA 修饰时受到限制,证实了核苷修饰在抑制 RNA 的免疫识别中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/4100ea74fb7c/gkr586f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/372493532294/gkr586f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/db7bfbbcc20f/gkr586f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/c9d14498b10f/gkr586f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/9c2c7ab24999/gkr586f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/d07fcbe8fe94/gkr586f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/144017d3d827/gkr586f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/4100ea74fb7c/gkr586f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/372493532294/gkr586f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/db7bfbbcc20f/gkr586f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/c9d14498b10f/gkr586f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/9c2c7ab24999/gkr586f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/d07fcbe8fe94/gkr586f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/144017d3d827/gkr586f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95be/3241635/4100ea74fb7c/gkr586f7.jpg

相似文献

1
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L.RNA 中的核苷修饰限制了 2′-5′寡聚腺苷酸合成酶的激活,并增加了对 RNase L 切割的抗性。
Nucleic Acids Res. 2011 Nov;39(21):9329-38. doi: 10.1093/nar/gkr586. Epub 2011 Aug 3.
2
Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.埃及果蝠源性 RoNi/7 细胞中 RNase L 的激活主要依赖于 OAS3,而不依赖于 MAVS 信号。
mBio. 2019 Nov 12;10(6):e02414-19. doi: 10.1128/mBio.02414-19.
3
Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.小鼠冠状病毒在髓样细胞中激活RNase L依赖于基础Oas基因表达且独立于病毒诱导的干扰素。
J Virol. 2016 Jan 6;90(6):3160-72. doi: 10.1128/JVI.03036-15.
4
Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.轮状病毒至少通过两种不同机制控制2'-5'-寡腺苷酸合成酶/RNase L途径的激活。
J Virol. 2015 Dec;89(23):12145-53. doi: 10.1128/JVI.01874-15. Epub 2015 Sep 23.
5
Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.在感染多种人类病毒期间,核糖核酸酶L的激活依赖于2′,5′-寡腺苷酸合成酶3(OAS3)的表达。
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2241-6. doi: 10.1073/pnas.1519657113. Epub 2016 Feb 8.
6
New insights into the role of RNase L in innate immunity.对 RNase L 在先天免疫中作用的新认识。
J Interferon Cytokine Res. 2011 Jan;31(1):49-57. doi: 10.1089/jir.2010.0120. Epub 2010 Dec 29.
7
Cell-type-specific effects of RNase L on viral induction of beta interferon.RNase L 对病毒诱导β干扰素的细胞类型特异性作用。
mBio. 2014 Feb 25;5(2):e00856-14. doi: 10.1128/mBio.00856-14.
8
RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.RNase L 的抗病毒活性并不是 Oas1b 介导的黄病毒抗性表型的关键组成部分。
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.00946-19. Print 2019 Nov 15.
9
Rotavirus NSP1 Subverts the Antiviral Oligoadenylate Synthetase-RNase L Pathway by Inducing RNase L Degradation.轮状病毒 NSP1 通过诱导 RNase L 降解来颠覆抗病毒寡聚腺苷酸合成酶-RNase L 途径。
mBio. 2022 Dec 20;13(6):e0299522. doi: 10.1128/mbio.02995-22. Epub 2022 Nov 22.
10
The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.2'-5'-寡腺苷酸合成酶3可高效合成核糖核酸酶L激活所需的2'-5'-寡腺苷酸。
J Virol. 2014 Dec;88(24):14222-31. doi: 10.1128/JVI.01763-14. Epub 2014 Oct 1.

引用本文的文献

1
Chemical Modifications in Nucleic Acid Therapeutics.核酸疗法中的化学修饰
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
Multisystem Endothelial Inflammation: A Key Driver of Adverse Events Following mRNA-Containing COVID-19 Vaccines.多系统内皮炎症:含mRNA的新冠疫苗接种后不良事件的关键驱动因素
Vaccines (Basel). 2025 Aug 12;13(8):855. doi: 10.3390/vaccines13080855.
3
Uridine as a hub in cancer metabolism and RNA biology.尿苷作为癌症代谢和RNA生物学的核心。

本文引用的文献

1
Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.核糖 2'-O-甲基化提供了一个分子特征,用于区分依赖 RNA 传感器 MDA5 的自我和非自我 mRNA。
Nat Immunol. 2011 Feb;12(2):137-43. doi: 10.1038/ni.1979. Epub 2011 Jan 9.
2
New insights into the role of RNase L in innate immunity.对 RNase L 在先天免疫中作用的新认识。
J Interferon Cytokine Res. 2011 Jan;31(1):49-57. doi: 10.1089/jir.2010.0120. Epub 2010 Dec 29.
3
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members.
Exp Mol Med. 2025 Aug 14. doi: 10.1038/s12276-025-01402-7.
4
RNA chemistry and therapeutics.RNA化学与治疗学。
Nat Rev Drug Discov. 2025 Jul 14. doi: 10.1038/s41573-025-01237-x.
5
Harnessing mRNA technology for ischemic heart disease: a review of regenerative and protective therapies.利用信使核糖核酸技术治疗缺血性心脏病:再生和保护性疗法综述
Cardiol Plus. 2025 Apr-Jun;10(2):117-128. doi: 10.1097/CP9.0000000000000118. Epub 2025 Jun 30.
6
Therapeutic Application of mRNA for Genetic Diseases.信使核糖核酸在遗传性疾病中的治疗应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 May-Jun;17(3):e70019. doi: 10.1002/wnan.70019.
7
Functions and therapeutic applications of pseudouridylation.假尿苷化的功能及治疗应用。
Nat Rev Mol Cell Biol. 2025 May 20. doi: 10.1038/s41580-025-00852-1.
8
From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment.从遗传密码到全球健康:核酸疫苗对疾病预防和治疗的影响。
RSC Med Chem. 2025 Apr 24. doi: 10.1039/d5md00032g.
9
The advent of clinical self-amplifying RNA vaccines.临床自扩增RNA疫苗的出现。
Mol Ther. 2025 Apr 3. doi: 10.1016/j.ymthe.2025.03.060.
10
Clinical development of therapeutic mRNA applications.治疗性mRNA应用的临床开发
Mol Ther. 2025 Jun 4;33(6):2583-2609. doi: 10.1016/j.ymthe.2025.03.034. Epub 2025 Mar 25.
病毒 mRNA 帽的 2'-O 甲基化逃避了 IFIT 家族成员的宿主限制。
Nature. 2010 Nov 18;468(7322):452-6. doi: 10.1038/nature09489.
4
The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells.Flvr 编码的鼠寡腺苷酸合成酶 1b(Oas1b)在完整细胞中抑制 2-5A 的合成。
Virology. 2011 Jan 20;409(2):262-70. doi: 10.1016/j.virol.2010.10.016. Epub 2010 Nov 5.
5
RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.RNase L 从 HCV RNA 释放出一种小 RNA,该 RNA 重新折叠成一种有效的 PAMP。
RNA. 2010 Nov;16(11):2108-19. doi: 10.1261/rna.2244210. Epub 2010 Sep 10.
6
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer.小核仁 RNA 特征作为非小细胞肺癌的生物标志物。
Mol Cancer. 2010 Jul 27;9:198. doi: 10.1186/1476-4598-9-198.
7
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.将假尿苷掺入信使核糖核酸(mRNA)可通过减少蛋白激酶R(PKR)的激活来增强翻译。
Nucleic Acids Res. 2010 Sep;38(17):5884-92. doi: 10.1093/nar/gkq347. Epub 2010 May 10.
8
2'-5'-Oligoadenylate synthetase is activated by a specific RNA sequence motif.2'-5'-寡腺苷酸合成酶由特定的RNA序列基序激活。
Biochem Biophys Res Commun. 2009 Oct 16;388(2):317-22. doi: 10.1016/j.bbrc.2009.07.167. Epub 2009 Aug 5.
9
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.将假尿苷掺入mRNA可产生具有更高翻译能力和生物稳定性的优质非免疫原性载体。
Mol Ther. 2008 Nov;16(11):1833-40. doi: 10.1038/mt.2008.200. Epub 2008 Sep 16.
10
Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner.核苷修饰以RNA结构特异性方式调节蛋白激酶PKR的激活。
RNA. 2008 Jun;14(6):1201-13. doi: 10.1261/rna.1007408. Epub 2008 Apr 21.